Notably, despite employing distinct analytical approaches, the results from both exploratory and validation study phases demonstrated significantly lower umbilical cord blood IL-17A levels in the PC group compared with the NPC group (p < 0.05). The gene discussed is IL17A; the disease is nasopharyngeal carcinoma.